Abstract
A sensitive and specific high-performance liquid chromatography-tandem mass method (LC-MS/MS) has been developed and validated for the simultaneous determination of baicalin, chlorogenic acid and forsythin in dog plasma using a chemical synthetic compound buspirone as the internal standard (IS). Chromatographic separation was accomplished on a Phenomenex Gemini C18 column (2.0 × 50 mm, I.D., 3.5 μm) with a gradient elution system composed of 0.1% formic acid in water and 0.1% formic acid in methanol at a flow rate of 0.40 mL min−1. Detection was based on a triple quadrupole mass spectrometer using a multiple reaction monitoring (MRM) mode with an electrospray ionization source (ESI). The precursor/product transitions (m/z) in the positive ion mode were 447.3 → 271.1, 355.3 → 163.3, 556.9 → 309.3, and 386.5 → 122.1 for baicalin, chlorogenic acid, forsythin and IS, respectively. All of the calibration curves showed good linearity (r > 0.995) over the concentration range of 1.0 to 1000 ng mL−1 and the lower limits of quantification (LLOQs) were all 1.0 ng mL−1 for three analytes. The intra-day and inter-day precisions (% RSD) of low-level QC samples were all less than 20% and the precisions (% RSD) of high- and medium-level were all less than 15%. The accuracies at three QC levels ranged from 80 to 120%. The mean recoveries were all above 80% for three analytes. All the three analytes in dog plasma were stable at three different conditions. The well-established and fully validated method was firstly applied to the pharmacokinetics of baicalin, chlorogenic acid and forsythin in dogs after intravenous administration of Shuang-huang-lian freeze-dried powder. Significant double and/or multiple-peak phenomena in plasma concentration–time profiles of three analytes were observed in all six dogs, which are thought to be the results of the enterohepatic cycle.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.